Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Synthesis And Biological Evaluation Of Radiolabeled Photosensitizer Linked Bovine Serum Albumin Nanoparticles As A Tumor Imaging Agent.

Aykut Ozgur, F. Y. Lambrecht, K. Ocakoglu, C. Gunduz, M. Yucebaş
Published 2012 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
In this study, we reported on the synthesis and biological evaluation of radiolabeled fluorescent dye conjugated bovine serum albumin nanoparticles within the size range 190-210 nm. The bovine serum albumin nanoparticles (BSANPs) were prepared using a desolvation method, and chemical cross-linking was performed using gluteraldehyde. Furthermore, pheophorbide-a (PH-A) was loaded on the BSANPs. The results obtained from dynamic light scattering and electron microscopy have proved that nanoparticles are highly monodisperse and near-spherical shaped. The photo-physical properties of the PH-A-BSANPs were obtained using the spectrophotometric techniques. According to the results, PH-A and BSANPs show high non-covalent interaction. PH-A loaded nanoparticles were labeled with (99m)Tc and the radio-labeling efficiency was determined as 90 ± 1.2%. Biodistribution studies of (99m)Tc labeled PH-A-BSANPs and PH-A were carried out using female Albino Wistar rats, and (99m)Tc-PH-A-BSANPs showed a significantly higher uptake in the breast and uterus than (99m)Tc-PH-A. Cell culture study was carried out in MCF-7 cell line (human breast adenocarcinoma cell line). According to the cell culture studies, (99m)Tc-PH-A-BSANPs showed a higher uptake than (99m)Tc-PH-A. Moreover, PH-A-BSANPs demonstrated good photo-physical properties and BSANPs increased the uptake of PH-A on to the MCF-7 cell line. These results confirm that (99m)Tc labeled PH-A-BSANPs could be utilized for radioimaging.
This paper references
10.4314/TJPR.V5I1.14634
Nanoparticles - A Review
V. Mohanraj (2007)
10.1111/j.1751-1097.1996.tb09643.x
Photodynamic Imaging of a Rat Pancreatic Cancer with Pheophorbide a
P. Keller (1996)
10.1016/J.ADDR.2003.08.015
Targeted photodynamic therapy via receptor mediated delivery systems.
W. M. Sharman (2004)
10.1016/j.apradiso.2011.03.047
Evaluation of 99mTc-Pheophorbide-a use in infection imaging: a rat model.
K. Ocakoglu (2011)
10.2174/1389450111314010013
Colloidal drug delivery systems in vaccine delivery.
S. Beg (2013)
10.1016/S1011-1344(02)00329-9
Preparation and biological evaluation of the new chlorin photosensitizer T3,4BCPC for detection and treatment of tumors.
S. Murugesan (2002)
10.1016/j.addr.2008.08.003
Nanoparticles in photodynamic therapy: an emerging paradigm.
D. Chatterjee (2008)
10.1016/S0378-5173(03)00134-0
Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
K. Langer (2003)
10.1016/s0969-8051(00)00092-5
Evaluation of (99m)Tc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy.
A. Babbar (2000)
10.1016/J.IJPHARM.2004.08.015
Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells.
L. Zhang (2004)
10.1002/chem.200800764
Structure-property relationships for self-assembled zinc chlorin light-harvesting dye aggregates.
Valerie Huber (2008)
10.1158/1078-0432.CCR-07-1441
Therapeutic Nanoparticles for Drug Delivery in Cancer
Kwangjae Cho (2008)
10.1021/JA00303A021
Meso substitution of chlorophyll derivatives: direct route for transformation of bacteriopheophorbides d into bacteriopheophorbides c
K. Smith (1985)
10.1016/j.jphotobiol.2009.04.006
Novel photosensitizer-protein nanoparticles for photodynamic therapy: photophysical characterization and in vitro investigations.
Kuan Chen (2009)
Distribution of pheophorbide A in normal tissues and in an experimental pancreatic cancer in rats.
M. Aprahamian (1993)
10.1016/S0969-8051(00)00123-2
Evaluation of (99m)Tc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy.
A. Babbar (2000)
10.1155/2008/276109
Photodynamic Therapy and the Development of Metal-Based Photosensitisers
L. B. Josefsen (2008)
10.1016/S0378-5173(99)00253-7
Preparation and in vitro characterization of HSA-mPEG nanoparticles.
W. Lin (1999)
10.1039/C0JM01544J
99mTc-hematoporphyrin linked albumin nanoparticles for lung cancer targeted photodynamic therapy and imaging
Su-Geun Yang (2010)
10.1016/S1359-0286(02)00117-1
Biodegradable nanoparticles for drug delivery and targeting
M. Hans (2002)
mTc-hematoporphyrin linked albumin nanoparticles for lung cancer targeted photodynamic therapy and imaging †
Su-Geun Yang (2010)
10.1016/j.jconrel.2008.05.010
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
F. Kratz (2008)
10.1002/LSM.20361
Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications
G. Jori (2006)
10.1016/J.FOODCHEM.2011.02.040
Preparation of size-controlled bovine serum albumin (BSA) nanoparticles by a modified desolvation method
Ji Yeon Jun (2011)
10.3109/10611861003622560
Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration
G. Wang (2010)
10.1016/j.ejpb.2010.04.008
Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
Kenneth Ofokansi (2010)
10.1016/j.ijpharm.2010.04.022
Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties.
M. Wacker (2010)
10.1016/S0378-5173(99)00420-2
Desolvation process and surface characteristics of HSA-nanoparticles.
C. Weber (2000)
10.1016/S0169-409X(96)00483-8
Nanoparticle drug delivery system for restenosis
V. Labhasetwar (1997)
Novel photosensitizerprotein nanoparticles for photodynamic therapy : harmaceutics 422 ( 2012 ) 472 – 478 photophysical characterization and in vitro investigations
A. Preuß (2009)



This paper is referenced by
10.1002/adhm.201601115
Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?
K. Pant (2017)
10.1080/07391102.2020.1722751
Surface modification of super paramagnetic iron oxide nanoparticles via milk casein for potential use in biomedical areas.
M. Esmaili (2020)
10.1007/s10967-015-4081-x
Primary evaluation of a nickel-chlorophyll derivative as a multimodality agent for tumor imaging and photodynamic therapy
Ozge Er (2015)
10.5603/NMR.2017.0002
Breast cancer: early diagnosis and effective treatment by drug delivery tracing.
Mahdiyeh Shamsi (2017)
10.1007/978-3-319-30705-3_22
Theranostic Nanoconjugates of Tetrapyrrolic Macrocycles and Their Applications in Photodynamic Therapy
J. Bhaumik (2016)
10.1039/c5dt00378d
Antitumor properties of platinum(iv) prodrug-loaded silk fibroin nanoparticles.
A. A. Lozano-Pérez (2015)
10.1142/9789814635424_0013
Protein-based Nanoparticles for Tumor Targeting Theranostics
Y. Liu (2016)
10.1088/0957-4484/24/3/035103
Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers.
B. Subia (2013)
10.1016/j.cis.2017.06.012
Impact of albumin based approaches in nanomedicine: Imaging, targeting and drug delivery.
B. Bhushan (2017)
10.1016/j.ijpharm.2015.07.047
131I-Zn-Chlorophyll derivative photosensitizer for tumor imaging and photodynamic therapy.
K. Ocakoglu (2015)
10.1007/s10856-015-5618-9
Application of albumin-based nanoparticles in the management of cancer
Xinzhe Yu (2015)
10.1007/s40495-019-00190-9
Application of Technetium 99 Metastable Radioactive Nanosystems: Nanoparticles, Liposomes, and Nanoemulsion for Biomedical Application
R. Santos-Oliveira (2019)
10.3109/1061186X.2014.958845
Evaluation of cancer imaging potential and photodynamic therapy efficacy of copper (II) benzyloxypheophorbide-a
K. Ocakoglu (2015)
10.1007/s12274-014-0628-3
Applications of phototheranostic nanoagents in photodynamic therapy
Jayeeta Bhaumik (2014)
10.2174/1381612826666200318170716
Nanomedicines In Diagnosis And Treatment Of Cancer: An Update.
N. Haider (2020)
10.5603/NMR.a2018.0008
A study on drug delivery tracing with radiolabeled mesoporous hydroxyapatite nanoparticles conjugated with 2DG/DOX for breast tumor cells.
Mahdiyeh Shamsi (2018)
10.1016/j.ejps.2017.09.037
New mesalamine polymeric conjugate for controlled release: Preparation, characterization and biodistribution study
A. A. Cesar (2018)
10.3390/biom9060218
Albumin Nanovectors in Cancer Therapy and Imaging
A. Parodi (2019)
10.1080/09205063.2019.1650241
Synthesis, photophysical and photobiological characterization of BSA nanoparticles loaded with chloroaluminium phthalocyanine by one-step desolvation technique for photodynamic therapy action
Alexandro da Silva Abreu (2019)
10.1002/jlcr.3097
Comparative biodistribution studies of technetium-99 m radiolabeled amphiphilic nanoparticles using three different reducing agents during the labeling procedure.
N. Geškovski (2013)
10.1039/C7TB02599H
Chlorin e6 loaded lactoferrin nanoparticles for enhanced photodynamic therapy.
Mahesh G. Adimoolam (2017)
10.1039/C6RA16426A
Lipid nanocarrier-based transport of docetaxel across the blood brain barrier
B. S. Satapathy (2016)
10.1002/jps.23181
Pharmaceutical aspects of the recombinant human serum albumin dimer: structural characteristics, biological properties, and medical applications.
K. Taguchi (2012)
10.1080/07391102.2019.1630320
The consequences of adopting therapeutic luminophore azapodophyllotoxin into BSA: a molecular regulator to control emissive population of two tryptophan residues in carrier protein
S. Mukherjee (2019)
10.1080/10717544.2020.1837296
Radioactive polymeric nanoparticles for biomedical application
Shentian Wu (2020)
Semantic Scholar Logo Some data provided by SemanticScholar